RT @FinutOrg: Algunas de sus publicaciones científicas más importantes: https://t.co/cknjI0neX4 https://t.co/gZpbxwTe8d https://t.co/kos7I…
RT @FinutOrg: Algunas de sus publicaciones científicas más importantes: https://t.co/cknjI0neX4 https://t.co/gZpbxwTe8d https://t.co/kos7I…
Algunas de sus publicaciones científicas más importantes: https://t.co/cknjI0neX4 https://t.co/gZpbxwTe8d https://t.co/kos7Iv2UsA https://t.co/QtXjRJX40B https://t.co/2tEazRSu39 https://t.co/7BVdEYaGnL https://t.co/Z1SQFxvPIY https://t.co/HAaInkGUJF https
The gut microbiota may explain some of metabolic alterations seen in obesity. The new RCT PROSIR from @CanalUGR, in which @fontanagallego & colleagues are involved, will evaluate the role of L. reuteri V3401 in patients with insulin resistance syndrome
RT @GMFHx: Obesity is closely related with functional diversity of the gut microbiota. @fontanagallego & colleagues explores the effect of…
GutMicrobiota Health on Twitter: "Obesity is closely related with functional diversity of the gut microbiota. .....,biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults via @BioMedCentral https://t.co/aNPR8fNj6L" / Twitter ht
RT @GMFHx: Obesity is closely related with functional diversity of the gut microbiota. @fontanagallego & colleagues explores the effect of…
RT @GMFHx: Obesity is closely related with functional diversity of the gut microbiota. @fontanagallego & colleagues explores the effect of…
Obesity is closely related with functional diversity of the gut microbiota. @fontanagallego & colleagues explores the effect of L. reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults via @BioMedCentral h
Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR). https://t.co/6auRaHtUY7
Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR). https://t.co/GgDGWLmmCn https://t.co/yWU7zi8Mj6